Xtant Medical Holdings, Inc. (XTNT) Financials

XTNT Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 92.6 million 41.3 million
2023-12-31 92.6 million 41.3 million
2023-09-30 92.0 million 37.3 million
2023-06-30 65.2 million 34.3 million

XTNT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -1.3 million 938000
2023-12-31 -1.3 million 938000
2023-09-30 -4.1 million 745000
2023-06-30 -2.9 million 439000

XTNT Net Income

No data available :(

XTNT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 5.9 million - -
2023-12-31 - - 1.8 million
2023-09-30 8.7 million - 1.8 million
2023-06-30 4.1 million 16.4 million 1.4 million

XTNT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 130.0 million
2023-12-31 130.2 million
2023-09-30 135.7 million
2023-06-30 108.9 million

XTNT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 363000 492000 8.9 million 11.6 million
2023-12-31 363000 492000 20.5 million -
2023-09-30 223000 490000 7.1 million 11.1 million
2023-06-30 414000 180000 5.0 million 8.7 million

XTNT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 28.1 million 11.0 million
2023-12-31 28.1 million 11.0 million
2023-09-30 25.0 million 9.7 million
2023-06-30 20.2 million 7.8 million

XTNT

Price: $0.82

52 week price:
0.60
1.45

Earnings Per Share: 0.01 USD

P/E Ratio: 52.75

Exchange: ASE

Sector: Healthcare

Industry: Medical Devices

Volume: 44500

Market Capitalization: 110.7 million

Links: